Bio Rad Laboratories Inc BIO

US Life Sciences Tools & Services

$381.00 ▼ -1.69% ($-6.54)

Open $384.14

Prev Close $387.54

Day Range $376.43 – $387.00

52W Range $236.73 – $396.23

Market Cap $10.23B

P/E (TTM) 46.11

Beta 1.08

EPS (TTM) $8.25

📋 Company Profile

Industry	Life Sciences Tools & Services
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	1980-03-17
Shares Out.	26,760,000
Website	bio-rad.com/ ↗
Phone	13026587581
Employees	7,450
Revenue	$651.0M
Gross Profit	$345.8M
Net Income	$371.4M
Free Cash Flow	$353.1M
Total Assets	$10.25B
Total Liabilities	$3.08B
Equity	$7.17B

About Bio Rad Laboratories Inc

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Bio Rad Laboratories Inc is a publicly traded company under the ticker symbol BIO on the NEW YORK STOCK EXCHANGE, INC., operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.